Trials / Completed
CompletedNCT00174473
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
An Open-label, Intravenous to Oral Switch, Multiple Dose Multi-Centre Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Hospitalized Children Aged 2 to 12 Years Who Require Treatment for the Prevention of Systemic Fungal Infections.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Voriconazole |
Timeline
- Start date
- 2003-06-01
- Completion
- 2005-08-01
- First posted
- 2005-09-15
- Last updated
- 2011-05-10
Source: ClinicalTrials.gov record NCT00174473. Inclusion in this directory is not an endorsement.